Drug Profile
Camicinal - GSK
Alternative Names: 962040; GSK 962040Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Amines; Gastrokinetics; Piperazines; Piperidines; Small molecules
- Mechanism of Action Motilin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Diabetic gastroparesis; Gastroparesis
Most Recent Events
- 28 Dec 2022 Discontinued - Phase-II for Gastroparesis in Australia (Enteral)
- 28 Dec 2022 Discontinued - Phase-II for Gastroparesis in Canada (Enteral)
- 28 Dec 2022 Discontinued - Phase-II for Gastroparesis in USA (Enteral)